Global Health Impact Network

What Global Health Impact Network does

Global Health Impact Network & Funds (GHIN&F) is a clinician-led healthcare investing platform headquartered in San Ramon, California, operating two interconnected entities: GHIN, a clinician network of 2,000+ physicians and subject-matter experts across 40+ medical specialties, and GHIF, a Silicon Valley-based venture capital fund targeting early-stage healthcare startups. The platform embeds clinical expertise into the investment lifecycle through clinician-led deal sourcing, due diligence, and portfolio support, with portfolio companies receiving clinical validation, introductions to hospital networks, and strategic guidance throughout the startup journey. GHIF I was launched in 2019, fully subscribed at $10M, and produced two exits from 10 investments, including Somnoware (acquired by ResMed in 2023 at a 3.3x return) and UBERDOC (acquired in 2025). GHIF II is currently fundraising with a $50M target and $25M first close, with 40% of GHIF I LPs having reinvested.

The business model combines traditional VC fund management economics (approximately 2% annual management fees on committed capital and 20% carried interest on profits above the hurdle) with adjacent revenue streams. These include the Wisdom Innovation Partners joint venture with Revere Partners targeting dental innovation, and a European transatlantic medtech advisory formalized with Sojo.consulting in May 2026 covering CEE, Nordics, DACH, UK, and Israel. The firm serves two primary customer sets: healthcare startup founders in digital health, medtech, precision medicine, and AI-powered diagnostics seeking capital and clinical validation, and clinician LPs seeking venture exposure and influence over healthcare innovation. Distribution relies on direct GP relationships, warm introductions, conference presence at JPM Week and HLTH, and clinician network referrals.

Name

Global Health Impact Network

Legal name

Global Health Impact Network & Funds

Website

https://globalhealthimpactnetwork.net

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Global Health Impact Network & Funds is a clinician-led healthcare investing platform combining a 2,000+ clinician network with a venture capital fund targeting early-stage healthcare startups. It serves healthcare startup founders seeking capital and clinical validation, and clinician LPs seeking venture exposure in digital health, medtech, and precision medicine.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

Keywords

• Healthcare venture capital
• Clinician network platform
• Early-stage medtech investing
• Digital health fund
• Precision medicine investing

Headquarters

HQ city

Walnut Creek

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Revenue model

1. Venture Capital Fund Management: GHIF generates revenue through management fees on committed capital (typically 2% of AUM) and carried interest (typically 20% of profits above the hurdle rate). GHIF I was launched in 2019 and fully subscribed at $10M. GHIF II is targeting $50M with first close at $25M.
2. Portfolio Company Returns: Returns realized through exits of portfolio companies. GHIF I achieved two successful exits: Somnoware (acquired by ResMed in 2023 with 3.3x return) and UBERDOC (acquired by ROV Investment Partners in 2025).

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Global Health Impact Network & Funds (GHIN&F) operates a clinician-driven healthcare investing platform comprising two core entities: the GHIN clinician network of 2,000+ medical professionals across 40+ specialties, and GHIF, a Silicon Valley-based venture capital fund that invests in early-stage healthcare, medtech, and digital health startups. The platform provides clinical due diligence, market validation, mentoring, and capital to founders, while enabling clinicians to participate as LPs and subject-matter experts.

Product overview

Global Health Impact Network & Funds (GHIN&F) operates as a clinician-led, network-driven Silicon Valley platform consisting of two primary offerings: GHIN (the clinician network platform) and GHIF (the venture capital fund). The platform is owned and led by clinicians, with access to 2,000+ clinicians and subject-matter experts across 40+ medical specialties. GHIF I (2019, $10M fully subscribed) has achieved two exits from 10 investments. GHIF II ($50M target, $25M first close) is currently fundraising. The ecosystem also includes Wisdom Innovation Partners (dental fund joint venture) and a European partnership with Sojo.consulting for transatlantic medtech advisory services. The company organizes portfolio companies across digital health, medical devices, AI-powered diagnostics, telemedicine, and specialty care (cardiovascular, maternal health, musculoskeletal, oncology, dental).

Differentiator

Problem solved

Functional benefit

Products and services

• Global Health Impact Network (GHIN) A clinician-driven healthcare investing platform providing a network of 2,000+ clinicians and subject-matter experts across 40+ medical specialties who participate in deal sourcing, clinical due diligence, market validation, and strategic value creation for medtech startups.
• Global Health Impact Fund (GHIF) A Silicon Valley-based venture capital firm investing in early-stage healthcare startups, leveraging the GHIN clinician network for deal sourcing, due diligence, and portfolio support across digital health, precision medicine, and medical technology.
• GHIF I Fund The inaugural venture fund launched in 2019, fully subscribed at $10 million, with 10 investments resulting in two successful exits: Somnoware (acquired by ResMed in 2023, 3.3x return) and UBERDOC (acquired by ROV Investment Partners in 2025).
• GHIF II Fund The second venture fund targeting $50 million with first close at $25 million, currently actively fundraising with 40% of GHIF I Limited Partners reinvested. Focus areas include women's health, Raydiant Oximetry Series B participation, and digital health innovation.
• Wisdom Innovation Partners A dental innovation fund launched in partnership with Revere Partners, targeting the dental market projected to grow to $731 billion by 2032, supporting startups such as Proteocyte and Decon7.

Quantifiable outcome

• 3.3x return from Somnoware exit (acquired by ResMed in 2023)
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

• Sojo.consultingcoreStrategic or Co-development Partner · 19 May 2026Formal European partnership established May 19, 2026, with appointment of Wojciech (Voytek) Majewski as GHIN Regional Director, Europe. Functions as boutique transatlantic medtech advisory connecting European founders with GHIN's U.S. clinician network. Sojo.consulting leads European client relationships end-to-end while GHIN provides clinical access. Formalizes nine months of joint pilot engagements in CEE cardiology and HIPAA-native build infrastructure. First Transatlantic Medtech Note co-authored by Voytek and GHIN clinician partner to be published Q3 2026.
• Revere PartnersflagshipStrategic or Co-development Partner · 11 June 2025Joint venture to launch Wisdom Innovation Partners dental fund targeting the underserved dental innovation market. GHIN&F and Revere Partners combine expertise to support dental startups like Proteocyte and Decon7. Market expected to grow to $731B by 2032. The fund addresses the gap where dental innovation receives limited VC attention despite $430B+ annual spending projected across OECD countries by 2030.
• GE HealthCarecoreStrategic or Co-development Partner · 16 May 2025Joint development initiative with Raydiant Oximetry (GHIF portfolio company) to enhance fetal monitoring capabilities. Combines expertise and technology to advance fetal oxygen saturation monitoring technology aimed at improving detection of fetal distress during childbirth and potentially reducing emergency cesarean section rates.
• Cross-Border Impact VenturesminorStrategic or Co-development PartnerParticipated in Women's Health Innovation Roundtable hosted by GHIN&F, along with UCSF. Cross-Border Impact Ventures (CBIV) represented by Managing Partners Annie Thériault and Megan Dover.
• UCSFminorStrategic or Co-development PartnerParticipated in Women's Health Innovation Roundtable hosted by GHIN&F, with Dr. Janet Moore Goldman (Maternal-Fetal Medicine Specialist) representing UCSF.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• angelMD: Physician-driven platform that connects clinicians with healthcare startups for investing, advisory, and clinical validation, mirroring GHIN's clinician-network-plus-fund model. Both monetize a network of doctors who evaluate and support early-stage healthcare deals.
• Life Science Angels: Bay Area-based angel network of healthcare and life-science professionals investing in early-stage biotech, medtech, and digital health startups. Comparable in being a domain-expert investor network writing checks at the seed/Series A stage, similar in scale to GHIF I.
• Wavemaker 360 Health: U.S. seed-stage venture fund focused exclusively on healthcare startups, with a similar clinician/expert network model that provides due diligence and portfolio support. Direct comparable on fund size, focus, and network-driven GTM.
• Healthtech Capital: Early-stage investor group focused on healthtech and digital health, built on a network of healthcare executives, physicians, and operators. Comparable in size, stage focus, and reliance on a community of clinical/industry experts for deal sourcing.
• Revere Partners: Dental-focused venture capital firm that co-launched Wisdom Innovation Partners with GHIF. A direct peer given the active JV relationship, comparable focus on a specialized healthcare vertical, and similar network-driven, clinician-adjacent investment model.

Emerging players

• Health Wildcatters: Dallas-based healthcare accelerator and seed fund that combines mentorship from clinicians and industry executives with seed capital. Overlaps with GHIF's clinician-led approach to early-stage healthtech investing, though structured as an accelerator cohort model.
• Excelestar Ventures: Early-stage healthtech and medtech investor leveraging an advisory network of physicians and industry experts for diligence and portfolio support. Comparable in targeting digital health/medtech seed deals with a network-led value proposition.
• RiverVest Venture Partners: St. Louis-based venture firm focused on healthcare and life sciences, investing in early- to growth-stage medtech, biopharma, and digital health. Comparable healthcare-only thesis and similar mid-sized fund strategy, though with more institutional LP base.

Broad incumbents

• OrbiMed: Largest dedicated healthcare investment firm globally, investing across biopharma, medtech, and digital health at all stages. Establishes the upper bound of healthcare VC scale and a benchmark for institutional deal flow, though GHIF targets earlier stages and smaller check sizes.
• New Enterprise Associates (NEA): Large multi-stage venture firm with a dedicated healthcare practice covering digital health, medtech, and biopharma. Provides scale and exit comp reference points for GHIF's portfolio outcomes, though at vastly greater AUM and check size.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/global-health-impact-network

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Health Impact Network